WallStSmart

CME Group Inc (CME)vsS&P Global Inc (SPGI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

S&P Global Inc generates 139% more annual revenue ($16.12B vs $6.76B). CME leads profitability with a 63.4% profit margin vs 30.5%. SPGI appears more attractively valued with a PEG of 1.96. SPGI earns a higher WallStSmart Score of 67/100 (B-).

CME

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.3Quality: 5.0
Piotroski: 2/9Altman Z: 0.30

SPGI

Strong Buy

67

out of 100

Grade: B-

Growth: 7.3Profit: 8.5Value: 5.0Quality: 5.5
Piotroski: 5/9Altman Z: 1.98

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.4%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Market CapQuality
$94.44B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

SPGI4 strengths · Avg: 9.3/10
Profit MarginProfitability
30.5%10/10

Keeps 31 of every $100 in revenue as profit

Operating MarginProfitability
44.8%10/10

Strong operational efficiency at 44.8%

Market CapQuality
$121.61B9/10

Large-cap with strong market position

Free Cash FlowQuality
$1.01B8/10

Generating 1.0B in free cash flow

Areas to Watch

CME4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

EPS GrowthGrowth
2.5%4/10

2.5% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

PEG RatioValuation
4.702/10

Expensive relative to growth rate

SPGI3 concerns · Avg: 4.0/10
PEG RatioValuation
1.964/10

Expensive relative to growth rate

P/E RatioValuation
25.3x4/10

Moderate valuation

Altman Z-ScoreHealth
1.984/10

Grey zone — moderate risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.4% and operating margin at 65.0%.

Bull Case : SPGI

The strongest argument for SPGI centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 30.5% and operating margin at 44.8%. Revenue growth of 10.4% demonstrates continued momentum.

Bear Case : CME

The primary concerns for CME are Revenue Growth, EPS Growth, Piotroski F-Score.

Bear Case : SPGI

The primary concerns for SPGI are PEG Ratio, P/E Ratio, Altman Z-Score.

Key Dynamics to Monitor

CME profiles as a value stock while SPGI is a mature play — different risk/reward profiles.

SPGI carries more volatility with a beta of 1.07 — expect wider price swings.

SPGI is growing revenue faster at 10.4% — sustainability is the question.

SPGI generates stronger free cash flow (1.0B), providing more financial flexibility.

Bottom Line

SPGI scores higher overall (67/100 vs 55/100), backed by strong 30.5% margins and 10.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

S&P Global Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

S&P Global Inc. is an American publicly traded corporation headquartered in Manhattan, New York City. Its primary areas of business are financial information and analytics.

Visit Website →

Want to dig deeper into these stocks?